New Methods for Evaluating Preventive Migraine Treatment
The study aims to test interactions between drug and placebo-responses in acute migraine treatment and to assess variation in adverse events according to treatment information provided. Using a clinical within-subjects, balanced placebo design, patients with chronic migraine will receive four treatment conditions in a randomized order.
Adults (18-65 years) [+4]
Use of onabotulinumtoxinA as preventive migraine treatment during the 4 months b... [+6]